Report for Hirano R

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (2)

Title : Effect of UGT1A1, CYP3A and CES Activities on the Pharmacokinetics of Irinotecan and its Metabolites in Patients with UGT1A1 Gene Polymorphisms - Yokokawa_2021_Eur.J.Drug.Metab.Pharmacokinet__
Author(s) : Yokokawa A , Kaneko S , Endo S , Minowa Y , Ayukawa H , Hirano R , Nagashima F , Naruge D , Okano N , Kobayashi T , Kawai K , Furuse J , Furuta T , Shibasaki H
Ref : Eur J Drug Metab Pharmacokinet , : , 2021
Abstract : Yokokawa_2021_Eur.J.Drug.Metab.Pharmacokinet__
ESTHER : Yokokawa_2021_Eur.J.Drug.Metab.Pharmacokinet__
PubMedSearch : Yokokawa_2021_Eur.J.Drug.Metab.Pharmacokinet__
PubMedID: 33619631

Title : Strigolactone perception and deactivation by a hydrolase receptor DWARF14 - Seto_2019_Nat.Commun_10_191
Author(s) : Seto Y , Yasui R , Kameoka H , Tamiru M , Cao M , Terauchi R , Sakurada A , Hirano R , Kisugi T , Hanada A , Umehara M , Seo E , Akiyama K , Burke J , Takeda-Kamiya N , Li W , Hirano Y , Hakoshima T , Mashiguchi K , Noel JP , Kyozuka J , Yamaguchi S
Ref : Nat Commun , 10 :191 , 2019
Abstract : Seto_2019_Nat.Commun_10_191
ESTHER : Seto_2019_Nat.Commun_10_191
PubMedSearch : Seto_2019_Nat.Commun_10_191
PubMedID: 30643123
Gene_locus related to this paper: arath-AtD14